Clinical trial
A Prospective Blinded Study to Evaluate and Characterise an Assay for the Diagnosis of Breast Cancer Using Synchrotron-Derived X-Ray Diffraction of Hair Fibres.
NCT00419679 is registered in ClinicalTrials.gov with Fermiscan Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Blinded Study to Evaluate and Characterise an Assay for the Diagnosis of Breast Cancer Using Synchrotron-Derived X-Ray Diffraction of Hair Fibres.
- Lead sponsor
- Fermiscan Ltd
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- December 31, 2006
- Completion date
- Not reported
- Enrollment
- 3,600
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.